Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

Costantino Ricci; Elisa Capizzi; Francesca Giunchi; Laura Casolari; Francesco Gelsomino; Karim Rihawi; Filippo Natali; Vanina Livi; Rocco Trisolini; Michelangelo Fiorentino; Andrea Ardizzoni

doi:10.1177/1758835920954802

Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

Costantino Ricci, Elisa Capizzi, Francesca Giunchi, Laura Casolari, Francesco Gelsomino, Karim Rihawi, Filippo Natali, Vanina Livi, Rocco Trisolini, Michelangelo Fiorentino, Andrea Ardizzoni

Risultato della ricerca: Contributo in rivista › Articolo

Lingua originale	Inglese
pagine (da-a)	1758835920954802-1758835920954809
Numero di pagine	8
Rivista	Therapeutic Advances in Medical Oncology
Volume	12
DOI	https://doi.org/10.1177/1758835920954802
Stato di pubblicazione	Pubblicato - 2020

Keywords

PD-L1
cytological smears
immunohistochemistry
non-small cell lung cancer

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1177/1758835920954802

Altri file e collegamenti

Open Access link a IRIS PubliCatt

Cita questo

Ricci, C., Capizzi, E., Giunchi, F., Casolari, L., Gelsomino, F., Rihawi, K., Natali, F., Livi, V., Trisolini, R., Fiorentino, M., & Ardizzoni, A. (2020). Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study. Therapeutic Advances in Medical Oncology, 12, 1758835920954802-1758835920954809. https://doi.org/10.1177/1758835920954802

@article{44efc8f0df32435091875ff238cb3e2b,

title = "Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study",

keywords = "PD-L1, cytological smears, immunohistochemistry, non-small cell lung cancer, PD-L1, cytological smears, immunohistochemistry, non-small cell lung cancer",

author = "Costantino Ricci and Elisa Capizzi and Francesca Giunchi and Laura Casolari and Francesco Gelsomino and Karim Rihawi and Filippo Natali and Vanina Livi and Rocco Trisolini and Michelangelo Fiorentino and Andrea Ardizzoni",

year = "2020",

doi = "10.1177/1758835920954802",

language = "English",

volume = "12",

pages = "1758835920954802--1758835920954809",

journal = "Therapeutic Advances in Medical Oncology",

issn = "1758-8340",

publisher = "SAGE Publications Inc.",

}

Ricci, C, Capizzi, E, Giunchi, F, Casolari, L, Gelsomino, F, Rihawi, K, Natali, F, Livi, V, Trisolini, R, Fiorentino, M & Ardizzoni, A 2020, 'Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study', Therapeutic Advances in Medical Oncology, vol. 12, pagg. 1758835920954802-1758835920954809. https://doi.org/10.1177/1758835920954802

Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study. / Ricci, Costantino; Capizzi, Elisa; Giunchi, Francesca et al.
In: Therapeutic Advances in Medical Oncology, Vol. 12, 2020, pag. 1758835920954802-1758835920954809.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

AU - Ricci, Costantino

AU - Capizzi, Elisa

AU - Giunchi, Francesca

AU - Casolari, Laura

AU - Gelsomino, Francesco

AU - Rihawi, Karim

AU - Natali, Filippo

AU - Livi, Vanina

AU - Trisolini, Rocco

AU - Fiorentino, Michelangelo

AU - Ardizzoni, Andrea

PY - 2020

Y1 - 2020

KW - PD-L1

KW - cytological smears

KW - immunohistochemistry

KW - non-small cell lung cancer

KW - PD-L1

KW - cytological smears

KW - immunohistochemistry

KW - non-small cell lung cancer

UR - http://hdl.handle.net/10807/261230

U2 - 10.1177/1758835920954802

DO - 10.1177/1758835920954802

M3 - Article

SN - 1758-8340

VL - 12

SP - 1758835920954802-1758835920954809

JO - Therapeutic Advances in Medical Oncology

JF - Therapeutic Advances in Medical Oncology

ER -